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ABSTRACT
The tumour-suppressor gene CDKN1A (encoding
p21Waf/Cip1) is thought to be epigenetically
repressed in cancer cells. FBI-1 (ZBTB7A) is a
proto-oncogenic transcription factor repressing
the alternative reading frame and p21WAF/
CDKN1A genes of the p53 pathway. FBI-1 interacts
directly with MBD3 (methyl-CpG–binding domain
protein 3) in the nucleus. We demonstrated that
FBI-1 binds both non-methylated and methylated
DNA and that MBD3 is recruited to the CDKN1A
promoter through its interaction with FBI-1, where
it enhances transcriptional repression by FBI-1. FBI-
1 also interacts with the co-repressors nuclear
receptor corepressor (NCoR), silencing mediator
for retinoid and thyroid receptors (SMRT) and BCL-
6 corepressor (BCoR) to repress transcription.
MBD3 regulates a molecular interaction between
the co-repressor and FBI-1. MBD3 decreases the
interaction between FBI-1 and NCoR/SMRT but
increases the interaction between FBI-1 and BCoR.
Because MBD3 is a subunit of the Mi-2 autoantigen
(Mi-2)/nucleosome remodelling and histone
deacetylase (NuRD)-HDAC complex, FBI-1 recruits
the Mi-2/NuRD-HDAC complex via MBD3. BCoR
interacts with the Mi-2/NuRD-HDAC complex,
DNMTs and HP1. MBD3 and BCoR play a significant
role in the recruitment of the Mi-2/NuRD-HDAC
complex– and the NuRD complex–associated
proteins, DNMTs and HP. By recruiting DNMTs and
HP1, Mi-2/NuRD-HDAC complex appears to play
key roles in epigenetic repression of CDKN1A by
DNA methylation.
INTRODUCTION
Factor that binds to the inducer of short transcripts of
human immunodeﬁciency virus-1 (FBI-1) (ZBTB7A) is a
recently characterized proto-oncoprotein of the POZ-
domain Kru¨ppel-like (POK) family of transcription
factors. It plays important roles in the cell cycle, cell dif-
ferentiation, proliferation, fatty acid synthesis, immune
responses and oncogenesis. FBI-1 promotes cellular trans-
formation by repressing alternative reading frame (ARF),
p21 and Rb expression, and has been shown to promote
cell proliferation and oncogenesis in the thymus, liver and
spleen in transgenic mice (1–3). We have demonstrated
that expression of the fatty acid synthase (FASN), which
is important in palmitate synthesis and cell proliferation in
cancer cells, is potently activated by FBI-1 in the presence
of sterol regulatory element binding protein-1 (SREBP-1)
(4). FBI-1 has also been shown to enhance NF-kB
mediated transcription by an interaction between the
POZ-domain and the Rel homology domain of NF-kB
(5). The mouse counterpart of FBI-1, the leukaemia/
lymphoma-related factor, is co-immunoprecipitated
and co-localized with proto-oncoprotein Bcl-6 (6).
FBI-1 is expressed in almost all tissues. Serial analysis
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of gene expression (SAGE), oncomine data and
immunohistochemistry analysis have shown that the ex-
pression of FBI-1 is increased in various cancer tissues.
DNA methylation is one of the epigenetic events that
can regulate gene expression [(7) and references therein]
and is important in transcriptional repression, genomic
imprinting, X-chromosome inactivation and genomic
stability. DNA from mammalian tissues is methylated at
70% of all CpG sites (8). Key exceptions to this global
methylation are the CpG islands, which are frequently
located in the 50-regulatory and/or promoter region.
CpG islands are non-methylated in germ cells, in early
embryos and in all somatic tissues (9). For the majority
of genes, the CpG islands of their 50-promoter regions are
not methylated and they are expressed.
DNA methylation is catalysed by DNA (cytosine-5)-
methyltransferase enzymes (DNMT 1, 3a or 3b) (10).
Aberrant DNA methylation patterns have been associated
with a large number of human malignancies and are found
in two distinct forms: hypermethylation and hypomethy-
lation when compared with normal tissue [(11,12) and
references therein]. Hypermethylation, which typically
occurs at CpG islands, represses transcription at the
promoter regions of tumour-suppressor genes, including
p16INK4a, p53, RB1 and BRCA1 [(12,13) and references
therein]. Global hypomethylation has also been implicated
in the development and progression of cancer through
genome instability (14).
The methyl-CpG–binding domain proteins (MBDs)
read and bind methylated DNA. MBD proteins recruit
additional chromatin remodelling proteins that can
modify histones to form compact silent chromatin.
Accordingly, they are mediators of epigenetic transcrip-
tional silencing of the hypermethylated promoters, as
was ﬁrst demonstrated for methyl CpG binding protein
2 (MeCP2) (15). The mammalian MBD protein class
contains ﬁve members, MBD1, MBD2, MBD3, MBD4
and MeCP2 (16). MBD3 is unique in that it cannot bind
to methylated DNA. With the exception of MBD4, which
is involved in DNA repair, all MBD proteins (MBD1,
MBD2 and MeCP2) associate with histone deacetylases
(HDACs) and couple DNA methylation to transcriptional
silencing through the modiﬁcation of chromatin [(17) and
references therein]. The molecular interaction between the
transcription repression domain of the MBD proteins and
the co-repressor complexes is important for the transcrip-
tional repression of methylated promoters [(18) and refer-
ences therein].
MBD3 is a component of the Mi-2 autoantigen
(Mi-2)/nucleosome remodelling and histone deacetylase
(NuRD)-HDAC complex (Mi-2/nuclesome remodelling
and deacetylase), a chromatin-remodelling complex that
contains a nucleosome remodelling ATPase, HDAC1
and HDAC2, and metastasis-associated protein 2
(MTA2) [(19) and references therein]. MBD3 has no in-
trinsic DNA-binding activity and is targeted to the
methylated promoter by interacting with MBD2 and
maintains transcriptionally repressed chromatin [(18)
and references therein; (20)]. Interestingly, MBD3
protein was shown to be associated with the proximal
promoter of CDKN1A and was released on treatment of
cancer cells with a HDAC inhibitor (21). The function
and mechanism of MBD3 association at the promoter
remains uncharacterized. By recruiting HDACs and
DNA methyltransferases (DNMTs), MBD3 acts as a tran-
scriptional repressor, which is important in oncogenic
transformation and cell proliferation (22). SAGE
analysis shows that FBI-1 and MBD3 are expressed
ubiquitously in most human tissues, with increased expres-
sion in various cancer tissues.
DNMT1 is the most abundant DNMT in mammalian
cells and considered to be the key maintenance
methyltransferase in mammals (23). DNMT1 predomin-
antly methylates hemimethylated CpG dinucleotides in the
mammalian genome. The enzyme is 7–100-fold more
active on hemimethylated versus unmethylated DNA
substrates in vitro, but it is still more active with respect
to de novo methylation than other DNMTs. DNMT3a
and DNMT3b are de novo methyltransferases and can
mediate methylation-independent gene repression.
DNMT3a can co-localize with the heterochromatin
protein (HP1) and the methyl-CpG–binding protein, and
can also interact with DNMT1. DNMTs can be targeted
to endogenous genes by interaction with site-speciﬁc tran-
scriptional repressor proteins, such as PML-RAR, which
cause hypermethylation of target genes in cancer cells (24).
It was proposed that DNMT1 represses the p21 promoter
by the mechanism that is not methylation dependent
(25,26). However, it was shown by chromatin immunopre-
cipitation (ChIP) assays that Myc is required for efﬁcient
recruitment of DNMT3a to the CDKN1A promoter and
the DNMT3a is required for gene silencing by promoter
DNA methylation (27).
The cyclin-dependent kinase inhibitor (CDKN1A, p21)
is a major player in mammalian cell cycle progression [(28)
and references therein]. It inhibits cyclin/cdk2 complexes
and interrupts cell cycle progression. CDKN1A is a tran-
scriptional target of p53 and plays a crucial role in
mediating growth arrest when cells are exposed to DNA-
damaging agents, suggesting that p21 has a tumour sup-
pression role (29). Overexpression of p21 results in G1-,
G2- or S-phase arrest. A variety of other factors, including
Sp1/Sp3, Smads, Ap2, STAT, BRCA1, E2F-1/E2F-3 and
C/EBPa and ß, activate the transcription of CDKN1A. In
addition to its role in the DNA-damage response, p21 has
also been implicated in terminal differentiation, replicative
senescence and protection from p53-dependent and -inde-
pendent apoptosis [(30) and references therein]. Recently,
we have shown that FBI-1 represses the transcription of
CDKN1A by binding competitively with p53 and Sp1 at
the distal and proximal regulatory elements, respectively,
which results in deacetylation of histones near the
proximal promoter (1).
Epigenetic silencing of CDKN1A gene expression in
cancer cells by histone modiﬁcation and promoter DNA
methylation is suggested by the upregulation of CDKN1A
gene expression after treatment with the HDAC inhibitor
trichostatin A (TSA) or the DNA methylation inhibitor 5-
aza-2’-deoxycytidine (31). The CDKN1A promoter was
also shown to be bound by MBD3 and was released on
treatment with the HDAC inhibitor, TSA (21). These data
suggest that the CDKN1A promoter is methylated and
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that histone deacetylation, DNA methylation and the
binding of MBD3 proteins may be related.
In this study, we investigated the function and mechan-
ism of the interaction between FBI-1 and MBD3 in the
epigenetic transcriptional regulation of CDKN1A, which
involves modiﬁcation of histones and DNA methylation
at the proximal CDKN1A promoter. This study illumin-
ates new roles of the proto-oncoproteins FBI-1, MBD3
and BCL-6 corepressor (BCoR) in the epigenetic regula-
tion of p21 expression, and perhaps in oncogenesis.
MATERIALS AND METHODS
Plasmid construction
Human MBD3 (GenBank: BC009372) cDNA was
ampliﬁed from a cDNA library using oligonucleotide poly-
merase chain reaction (PCR) primers: forward, 50-GATCC
TCGAGACCATGGAGCGGAAGAGCCCG-30; reverse,
50-GATCAAGCTTGACGTGCTCCATCTCCGG-30.
The ampliﬁed cDNA fragment was inserted into the XhoI
and HindII site of pcDNA3.1 (Invitrogen, Carlsbad, CA).
All plasmid constructs were veriﬁed by sequencing. The
CDKN1A-Luc plasmid was kindly provided by Dr.
Yoshihiro Sowa of Kyoto Perpetual University of
Medicine (Kyoto, Japan). Plasmids, including pPac-PL-
FBI-1, pGL2-CDKN1A-Luc (133 bp), pGL2-5x(FRE)-
Luc and pCMX-GAL4-ZF-FBI-1, co-repressors and
pCMX-VP16-co-repressors were reported elsewhere (2).
The pPac-PL-MBD3 plasmid was prepared by cloning
the cDNA fragment into pPac-PL. All plasmid constructs
were veriﬁed by sequencing. To prepare the glutathione S-
transferase (GST)-POZFBI-1 and GST-ZFFBI-1 fusion
protein expression plasmids, cDNA fragments encoding
the POZ-domain and ZF of FBI-1 were subcloned into
pGEX4T3 (Amersham Biosciences, NJ) and reported else-
where (1). Antibodies against GAPDH, GST, MBD3 and
Flag-Tag were purchased from Chemicon (Temecula, CA),
Calbiochem (San Diego, CA), SantaCruz Biotechnology
(Santa Cruz, CA) and Sigma (St. Louis, MO), respectively.
In vitro methylation of pG5-5x(FRE)-Luc reporter
plasmid and preparation of FRE and methylated FRE
pG5-5x(FRE)-Luc reporter plasmid was incubated with
SssI (New England Biolabs, Beverly, MA) to methylate
the plasmid according to the manufacturer’s instruction.
Methylation was conﬁrmed by restriction digestion with
BstUI and HpaII for 16 h at 60C and agarose-gel electro-
phoresis. Oligonucleotide sequences used for the FRE (or
methylated FRE) and FBI-1 interactions are as follows:
FRE (forward, 50-GATCCGAGCGCGGGTCCCGCCT
C-30; reverse, 50-GATCGAGGCGGGACCCGCGCTCG
-30), methylated oligonucleotide probes were synthesized
by Intergrated DNA Technologies (Coralville, IA).
Methylated oligonucleotide probes used are as follows:
Me-FRE (forward, 50-GATC/5-Methyl-dC/GAG/
5-Methyl-dC/G/5-Methyl-dC/GGGTCC/5-Methyl-dC/G
CCTC-30; reverse, 50-GATCGAGG/5-Methyl-dC/GGGA
CC/5-Methyl-dC/G/5-Methyl-dC/GCT/5-Methyl-dC/G-30).
Chromatin immunoprecipitation (ChIP)/reChIP assays
The molecular interaction between FBI-1 and MBD3 on
the pGL2-5x(FRE)-Luc was analysed by ChIP assays.
HEK293 cells were transfected with pGL2-5x(FRE)-Luc
or methylated pGL2-5x(FRE)-Luc (2 mg), pcDNA3.0-
FLAG-FBI-1 and pcDNA3.1-MBD3 (2mg) using
Lipofectamine Plus. Cells were ﬁxed with formaldehyde
(ﬁnal 1%) to cross-link FBI-1 and MBD3 on the
5x(FRE). The remainder of the ChIP procedure is
reported elsewhere (2). PCR reactions of chromatin-
immunoprecipitated DNA were carried out using oligo-
nucleotide primer sets designed to amplify the region
ﬂanking the FRE elements of CDKN1A: forward, 50-GG
TACTGTAACTGAGCTA-30; reverse, 50-GATCCAGAT
CTCGAGCTA-30.
For ChIP-reChIP assays of FBI-1 and MBD3 binding
at the CDKN1A proximal promoter, the ﬁrst ChIP
samples using anti-FBI-1 antibody or anti-MBD3
antibody were diluted 10 times with dilution buffer
(15mM Tris–HCl, pH 8.1, 1% Triton X-100, 1mM
EDTA, 150mM NaCl) and immunoprecipitated using
anti-MBD3 or anti-FBI-1 antibodies. Negative control
ChIP assays were carried out with rabbit IgG antibody.
The 30-UTR of CDKN1A was used as a negative control
region of protein–DNA interaction using the following
oligonucleotide primers: forward, 50-TCCTTCCCATCG
CTGTCACA-30; reverse, 50-GTCACCCTGCCCAACCT
TAG-30.
The histone modiﬁcations were investigated by ChIP
assay. HEK293 cells were transfected with pcDNA3.0-
FLAG-FBI-1 and/or pcDNA3.1-MBD3 (2 mg) using
Lipofectamine Plus (Invitrogen, Carlsbad, CA). Also,
primary human dermal ﬁbroblast neonatal (HDFn)
cells were transfected with various combinations of
pcDNA3.0-FLAG-FBI-1 (5 mg), pcDNA3.1-MBD3
(5mg), FBI-1 siRNA (100 pmoles) and/or MBD3 siRNA
(100 pmoles) using the Neon Kit of the Neon Transfection
System (Invitrogen, Carlsbad, CA) according to the
manufacturer’s instructions (Supplementary Table 1).
After 48 h, cells were harvested and the ChIP assay was
performed as described above. Rabbit polyclonal IgG
(Labfrontier, Seoul, Korea), anti-acetyl-Histone 3, anti-
acetyl-Histone 4, anti-trimethyl-Histone H3 lysine 4
(H3K4-Me3) and anti-trimethyl-Histone H3 lysine 9
(H3K9-Me3) (Upstate, Lake Placid, NY) antibodies
were used. To analyse modiﬁcations of histone 3 and
histone 4 around the proximal CDKN1A promoter, the
following oligonucleotide primers were used: forward, 50-
GCGCTGGGCAGCCAGGAGCC-30; reverse, 50-CGCT
CTCTCACCTCCTCT-30.
To analyse the DNA methylation at the proximal
CDKN1A promoter by ChIP, a Me-DIP kit (Diagenode,
Lie`ge, Belgium) designed to immunoprecipitate methy-
lated DNA with an anti-methylated-DNA antibody was
used.
Immunoprecipitation assays
Cells were washed with PBS, pelleted by centrifugation
and resuspended in lysis buffer (20mM Tris–HCl, pH
7.5, 150mMNaCl, 10% glycerol and 1% Triton X-100)
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supplemented with a protease inhibitor cocktail. Cell
lysate was collected by centrifugation, pre-cleared by in-
cubation with protein A-Sepharose Fast Flow (Sigma,
St. Louis, MO), pre-equilibrated with lysis buffer on a
rotating platform, centrifuged and the supernatant was
collected. Supernatants were incubated with the primary
antibody and further incubated with protein G-Sepharose
Fast Flow beads pre-equilibrated in lysis buffer.
Beads collected by centrifugation were washed and resus-
pended in an equal volume of 5SDS loading buffer.
Immunoprecipitated proteins were separated by 12%
sodium dodecyl sulphate-polyacrylamide gel electrophor-
esis (SDS-PAGE). Western blot assays were performed as
described above.
DNA methylation analysis by bisulﬁte DNA sequencing
Genomic DNA was puriﬁed with the Wizard
genomic DNA puriﬁcation kit (Promega, Madison, WI).
Methylation analyses were performed by bisulﬁte conver-
sion of genomic DNA using the EpiXploreTM Methyl
Detection kit (Clontech, Palo Alto, CA). The primer
sequences used to amplify the CDKN1A promoter
region were sense 50-AGGAGGGAAGTGTTTTTTTGT
AGTA-30 and antisense 50-ACAACTACTCACACCTCA
ACTAAC-30. The PCR product was cloned using the
pGEM-T Easy vector System I kit (Promega, Madison,
WI). Mini-scale plasmid DNA was prepared from >30
individual transformed Escherichia coli and were
sequenced.
RESULTS
Proto-oncoprotein FBI-1 interacts with MBD3
To understand the biological functions of the proto-
oncogene FBI-1, we isolated a nuclear protein complex
containing FBI-1 from stable HEK293-TREx-FLAG-
FBI-1 cells by immunoprecipitation using anti-FLAG-
M2-agarose beads. The immunoprecipitates were
separated by a 2D isoelectric focusing gel (Supplementary
Figure S1A and B). A 34 kDa protein band was excised
from the gel, digested with trypsin and subjected to
matrix-assisted laser desorption/ionization–time of ﬂight
mass spectrometry analysis. Database searches for
peptide mass ﬁngerprinting using the MASCOT
program (Matrix Science Ltd., London, UK) revealed
that the protein was MBD3 (Supplementary Figure S2A
and B).
To characterize the interaction between MBD3 and
FBI-1, nuclear extracts prepared from the control and
doxycycline-induced stable HEK293-TREx-FLAG-FBI-1
cells were co-immunoprecipitated using the anti-FLAG
M2 antibody or IgG-conjugated agarose beads as a
control. Western blotting analysis of the immunopre-
cipitates using antibodies against MBD3 and FLAG
showed that FBI-1 interacts with MBD3; reciprocal co-
immunoprecipitations (co-IPs) of the same nuclear extract
and western blot assays also demonstrated speciﬁc bind-
ing between endogenous MBD3 and FBI-1 (Figure 1A
and B). GST-fusion protein pull-down assays showed
that MBD3 interacted directly with the zinc-ﬁnger
DNA-binding domain of FBI-1 (GST-ZF; Figure 1C).
FBI-1 co-localized with the MBD3 protein in the
nucleus of HeLa cells transfected with expression vectors
of FLAG-FBI-1 and/or His-tagged MBD3 (data not
shown). The above data, along with proteomic data,
suggest that FBI-1 directly interacts with MBD3 in
nucleus.
MBD3 enhances transcriptional repression of
CDKN1A by FBI-1
Using the two promoter-luciferase reporter fusion
constructs that contained either distal and/or proximal
FBI-1 target sites (1) (Figure 2A), we examined whether
MBD3 affected transcription repression of CDKN1A by
FBI-1 in HEK293 cells. As we reported previously, FBI-1
repressed transcription of the reporter constructs, and
MBD3 alone weakly repressed transcription, possibly by
interacting with endogenous FBI-1 (1). However, when
FBI-1 and MBD3 were co-transfected, strong transcrip-
tional repression was observed for both promoter
constructs (Figure 2B and C), suggesting that the FBI-1-
MBD3 interaction is important for transcriptional
repression on the proximal promoter. Western blot
assays of cell lysates prepared from the HeLa cells
transfected with combinations of FBI-1 and/or MBD3 ex-
pression vectors showed that MBD3-FBI-1 co-expression
also potently repressed expression of endogenous p21
(Figure 2D).
Using a loss of function approach, we tested whether
endogenous FBI-1 and MBD3 are important for the tran-
scriptional repression of CDKN1A in HEK293 cells.
Knock-down of FBI-1 resulted in derepression of the
CDKN1A gene as reported previously (1). Knock-down
of MBD3 also resulted in derepression. Knock-down of
both FBI-1 and MBD3 resulted in the most robust dere-
pression (Figure 2E and Supplementary Figure S3).
Western blot assays of the cell lysates prepared from the
cells transfected with siRNAs against FBI-1 and/or
MBD3 revealed an increased expression of endogenous
p21 (Figure 2F). These data suggest that MBD3 can
enhance the transcriptional repression of CDKN1A by
FBI-1 and that the FBI-1-MBD interaction may be sig-
niﬁcant in cell cycle regulation by repressing p21
expression.
FBI-1 binds to the methylated and non-methylated
FBI-1–binding DNA element (FRE) of the CDKN1A
promoter in vitro. MBD3 binding is increased by FBI-1
and enhances transcriptional repression by FBI-1
MBD3 enhances transcriptional repression by FBI-1
bound to the FRE (GC-box #3, 104 to 90 bp) in the
proximal promoter of CDKN1A. We tested whether tran-
scriptional repression of pG5-5x(FRE)-Luc by FBI-1
could be further repressed by MBD3 in HEK293 cells
and Drosophila SL2 cells lacking mammalian MBD3
and FBI-1. FBI-1 repressed transcription in both cell
lines; MBD3 could not repress transcription of pG5-
5x(FRE)-Luc in SL2 cells because SL2 cells lack endogen-
ous human FBI-1. However, co-expression of MBD3 and
FBI-1 in SL2 cells resulted in more signiﬁcant repression
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(Figure 3A). These data suggested that transcriptional
repression by MBD3 requires FBI-1 bound to the FRE.
MBD proteins (MBD1, 2, 4, 5 and MeCP2) can bind to
methylated DNA. Although MBD3 cannot bind to DNA
directly, it may be targeted to the FRE by interacting
with FBI-1 bound at the proximal promoter. By electro-
mobility shift assay (EMSA), we demonstrated that the
recombinant zinc-ﬁnger DNA-binding domain of FBI-1
(ZF-FBI-1) bound to the FRE probe and, interestingly,
that FBI-1 also bound to the methylated FRE probe,
although rather weakly. This binding was eliminated by
excess unlabelled probe (Figure 3B). These data suggest
that FBI-1, like KAISO, may be involved in recognizing
both methylated and non-methylated DNA elements, such
as FRE, and silencing of FBI-1 target genes.
We also tested whether FBI-1 and MBD3 could bind
the probes using DNA pull-down assays. The cell lysates
prepared from HEK293 cells transfected with pcDNA3 or
pcDNA3-FLAG-FBI-1 expression vector were incubated
with FRE or methylated FRE probe conjugated to
streptavidin-agarose beads. Western blot analysis of the
precipitates with anti-FBI and anti-MBD3 antibodies
showed that FBI-1 can bind both non-methylated
FRE and methylated FRE probes and that ectopic
FBI-1 enhances binding of MBD3 to the probes
(Figure 3C).
FBI-1 binds to both methylated and non-methylated FRE
in HEK293 and SL2 cells, and recruits MBD3 to the
CDKN1A promoter
Using ChIP assays, we also investigated whether FBI-1
and MBD3 could bind to the proximal CDKN1A
promoter that contains six copies of the methylated
and non-methylated FRE of pG5-(5xFRE)-Luc in vivo
(Figure 4A). The pG5-(5xFRE)-Luc plasmid and the
methylated pG5-(5xFRE)-Luc plasmid used in the assays
were prepared by treatment with the CpG methyltrans-
ferase, SssI. Methylation of the plasmid with SssI
resulted in complete resistance to digestion by the
methylated DNA-speciﬁc restriction enzymes, BstUI and
HpaII (Figure 4A). We transfected HEK293 and
Drosophila SL2 cells with either the pG5-5x(FRE)-Luc
plasmid or the methylated pG5-5x(FRE)-Luc plasmid
and analysed FBI-1 and MBD3 binding by ChIP assay.
As in the DNA pull-down assays, FBI-1 was able to bind
both non-methylated and methylated FRE in both types
of cells. MBD3 bound the FRE alone in HEK293 cells,
most likely by interacting with endogenous FBI-1. MBD3
bound to the FRE only in the presence of co-transfected
FBI-1 in SL2 cells (Figure 4B and C lane 3). These data
suggest that MBD3 binds to the promoter by interacting
with endogenous FBI-1.
Figure 1. FBI-1 interacts directly with MBD3. (A) Co-IP and western blot analysis. HEK293T-REX-control and stable HEK293T-REX-FLAG-
FBI-1 cell nuclear extracts were immunoprecipitated with anti-FLAG M2 agarose beads, and the precipitates were analysed by western blot using the
indicated antibodies. (B) Reverse co-IP of (A). The same nuclear extracts were immunoprecipitated with an antibody against MBD3, and the pre-
cipitates were analysed by western blot using the anti-FLAG antibody. (C) GST-fusion protein pull-down assays. Schematic diagram of the domains
of FBI-1 tested. Recombinant GST protein, GST-POZFBI-1 and GST-ZFDBDFBI-1 were incubated with in vitro synthesized [35S]-methionine-
labelled MBD3, precipitated, resolved by 10% SDS-PAGE and analysed by autoradiography.
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We examined if ectopic expression or knock-down
of MBD3 expression affected MBD3 binding at the en-
dogenous CDKN1A promoter using qChIP assays. FBI-1
expression increased endogenous MBD3 binding, as did
MBD3 overexpression; co-expression of FBI-1 and MBD3
further increased MBD3 binding (Figure 4D and E left).
Knock-down of MBD3 expression nearly eliminated
MBD3 binding in the region (Figure 4D and E and
Supplementary Figure S3). In contrast, ectopic MBD3
did not affect FBI-1 binding (Figure 4F).
Furthermore, we examined whether ectopic or endogen-
ous (as demonstrated by knock-down) FBI-1 and MBD3
could be bound to the proximal promoter of p21WAF/
CDKN1A simultaneously via ChIP-reChIP assays with
Figure 2. MBD3 enhances transcriptional repression of the CDKN1A gene by FBI-1. (A) Structures of the two CDKN1A-luc fusion reporter
constructs tested. (B and C) Transient transcription assays in HEK293 cells. Cells were transfected with each luciferase reporter construct and
the expression vectors for MBD3 and FBI-1. The average of three independent assays is shown; bars represent standard deviations. (D) Western blot
analysis. HEK293 cells were transfected with MBD3 and/or FBI-1 expression vector. Cell lysates were analysed for endogenous p21 expression.
Ectopic FBI-1 and MBD3 expression potently repress endogenous CDKN1A expression. (E) Transient transcription assays in HEK293 cells.
Knock-down of FBI-1 or/and MBD3 derepressed reporter gene expression from the p21WAF/CDKN1A-Luc (131 bp) construct. Luciferase
activities were normalized to protein concentration. The average of three independent experiments is shown. Bars represent standard deviations.
(F) Western blot analysis. HEK293 cells were transfected with MBD3 siRNA and/or FBI-1 siRNA. Cell lysates were analysed for endogenous
p21 expression. Knock-down of endogenous FBI-1 and/or MBD3 expression increases endogenous p21 expression. Negative control, scrambled
siRNA.
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anti-FBI-1 and anti-MBD3 antibodies. The results showed
that FBI-1 and MBD3 were bound to each other. In
contrast, neither FBI-1 nor MBD3 was bound to the 30-
UTR region of the gene used as a negative control (Figure
4G–J). These data suggested that MBD3 is recruited to the
non-methylated FRE and methylated FRE in vivo by mo-
lecular interaction with FBI-1.
MBD3 recruited by FBI-1 affects the molecular
interaction between FBI-1 and co-repressors, and drives
FBI-1 to interact with BCoR.
Previously, we showed that FBI-1 can interact with
co-represssor–HDAC complexes such as nuclear receptor
corepressor (NCoR), silencing mediator for retinoid and
thyroid receptors (SMRT) and BCoR and that the FBI-1–
co-repressor complex deacetylates histones H3 and H4 to
repress transcription (1). Because MBD3 enhances tran-
scriptional repression by FBI-1, we investigated whether
MBD3 affects the protein interactions between co-repres-
sors and FBI-1.
We have shown that the POZ-domain (very weak, data
not shown) and the zinc-ﬁngers of FBI-1 interact with
co-repressors (Figure 1D). Mammalian two-hybrid
assays showed that the zinc-ﬁnger domain binding
domain (ZFDBD) of FBI-1 interacts with SMRT,
NCoR and BCoR and that its interaction with SMRT
and BCoR were relatively strong compared with its inter-
action with NCoR. However, in the presence of MBD3,
the interaction between FBI-1 and SMRT or NCoR is
considerably decreased, but the interaction between
BCoR and FBI-1 is increased (Figure 5A). Additionally,
co-IP and western blot analysis revealed that BCoR,
MBD3 and FBI-1 form a complex and that the molecular
interaction with BCoR is increased by the presence of
MBD3 (Figure 5B lane 4), while the molecular interaction
between FBI-1 and MBD3 is proportional to the amount
of FBI-1 present (Figure 5B). Due to the nature of mam-
malian two-hybrid assays, one might argue that the
change in the strength of interactions might reﬂect the
ability of the MBD3-associated NuRD complex to coun-
teract the action of VP16 rather than provide a real indi-
cation of how well the proteins interact. However, the
ChIP assays also showed that knock-down of MBD3
mRNA increased NCoR recruitment but decreased
Figure 3. MBD3 enhances transcriptional repression of pG5-5x(FRE)-Luc by FBI-1. FBI-1 binds to both methylated and unmethylated FRE
elements of CDKN1A, and MBD3 binding to the FRE probes is increased by ectopic FBI-1. (A) Transient transcription assays in HEK293 cells
and Drosophila SL2 cells. Cells were transfected with the reporter construct, mammalian or Drosophila (pPac) expression vector of FBI-1 and/or
MBD3. All data shown are the average of three independent assays; bars represent standard deviations. (B) EMSA. 32P-labelled FRE and methylated
FRE probes were incubated with recombinant GST-ZF-FBI-1 protein (500 ng), separated by 4% non-denaturing polyacrylamide gel electrophoresis,
and the dried gel was exposed to radiographic ﬁlm. (C) Oligonucleotide pull-down assay. Nuclear extracts from HEK293 control or HEK293 cells
transfected with the FLAG-FBI-1 expression vector were incubated with biotinylated double stranded oligonucleotides corresponding to the FRE
and methylated FRE. The precipitated complexes were analysed by western blotting using the anti-FLAG and anti-MBD3 antibodies. GAPDH was
used as a control.
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Figure 4. MBD3 binding to the FRE element requires FBI-1 in vivo. (A) Methylation of the FBI-1 responsive reporter, pG5-5x(FRE)-Luc, with the
methylase SssI. Plasmid methylation was tested by digestion with methylated DNA-speciﬁc endonucleases BstUI and HpaII. M, DNA size marker.
Lanes 1–3, unmethylated plasmid. Lanes 4–6, methylated plasmid. (B) ChIP assays of FBI-1 and MBD3 binding on the proximal promoter of
pG5-5x(FRE)-Luc and the methylated plasmids transfected into HEK293 cells. ChIP primer sets were designed to amplify the region ﬂanking the
proximal FRE elements. Arrows indicate the primer-binding sites. (C) ChIP assays of FBI-1 and MBD3 binding in Drosophila SL2 cells lacking
mammalian transcription factors. MBD3 binding requires FBI-1. (D) Structure of the human CDKN1A gene promoter. Arrows at the promoter
regions indicate the locations of ChIP PCR primer-binding sites. (E) qChIP assays of MBD3 binding to the endogenous CDKN1A promoter under
ectopic expression of FBI-1 and/or MBD3, or knock-down of MBD3 in HEK293 cells. MBD3 binding is increased by ectopic FBI-1 and/or MBD3
(F) qChIP assays of FBI-1 in the presence of ectopic FBI-1 and/or MBD3. (G–J) ChIP-reChIP assays of FBI-1 and MBD3 binding at the proximal
CDKN1A promoter by ectopic expression or knock-down of either FBI-1 or MBD3. The negative controls were IgG and the 30-UTR.
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Figure 5. MBD3 increases the protein interaction between FBI-1 and co-repressor BCoR. The MBD3–FBI-1 interaction and BCoR recruitment
decreases histone acetylation and histone H3K4-Me3 but increases histone H3K9-Me3. (A) Mammalian two-hybrid assay of molecular interaction
between co-repressor and FBI-1. HEK293 cells were transiently transfected with the plasmids indicated (200 ng of reporter plasmid, GAL4 fused
FBI-1-ZF, VP-16 fused proteins and MBD3 expression vector). All data represent the average of three independent assays and bars represent
standard deviations. (B) Co-IP and western blotting. HEK293 cells were transfected with the expression vectors, cell lysates were immunoprecipitated
and analysed by western blotting using the indicated antibodies. (C) Structure of the human CDKN1A gene promoter. Arrows indicate the locations
of ChIP PCR primer-binding sites. (D) qChIP assays of co-repressor switching (NCoR, BCoR) at the proximal CDKN1A promoter by knock-down
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BCoR recruitment (Figure 5D and E). This suggests that
by interacting with FBI-1, MBD3 decreases NCoR
binding and increases BCoR binding, which is in line
with the mammalian two-hybrid assay and co-IP results
(Figure 5A and B).
Because interaction with the transcription co-repressor
complex changes the modiﬁcations of chromatin, we
investigated the changes in epigenetic histone marks by
FBI-1, MBD3 and BCoR recruited to the proximal
promoter of CDKN1A. As expected, given the transcrip-
tional repressor roles of MBD3 and FBI-1, the two
proteins decreased the acetylation of histones H3 and
H4 and the trimethylation of histone H3K4.
Interestingly, when co-expressed with FBI-1, MBD3
increased the trimethylation of histone H3K9, an indica-
tor of transcriptionally repressed chromatin (Figure 5F
and G).
We also examined whether a loss of function of MBD3
or BCoR affected the histone methylation marks of
histone H3. Knock-down of either MBD3 or BCoR
expression resulted in an increase in H3K4-Me3 and a
decrease in H3K9-Me3, indicating transcription derepres-
sion (Figure 5H). While knock-down of MBD3 mRNA
resulted in a decrease in BCoR binding, an absence of
BCoR or a decrease in BCoR levels did not affect the
recruitment of MBD3 to the proximal promoter, which
indicates that BCoR recruitment requires MBD3
(Figure 5I and Supplementary Figure S9). Knock-down
of MBD3 mRNA did not affect BCoR mRNA expression
or vice versa (Figure 5J)
These data suggest that both MBD3 and BCoR have
effects on the modiﬁcation of histone H3 that are related
to transcriptional repression. It appears that, once
recruited to the target promoter by FBI-1, MBD3 causes
a switch in the FBI-1 from interacting with co-repressor to
BCoR, which results in the deacetylation of histones,
demethylation of H3K4-Me3 and trimethylation of
H3K9.
MBD3 and FBI-1 cause DNA methylation of the
CDKN1A proximal promoter by recruiting the Mi-2/
NuRD-HDAC complex and BCoR
The CDKN1A gene is regulated by histone deacetylation
(1) and potentially by DNA methylation of the proximal
promoter, which is GC rich. Histone modiﬁcation to
H3K9-Me3 by MBD3 suggests that CDKN1A may be
repressed by DNA methylation (Figure 5F–H).
Because a nucleosome-like structure was reported to be
formed on the transfected promoter-reporter fusion
plasmid DNA (32,33), we investigated whether the
nucleosomal histone and the DNA around the minimal
promoter fused to the luciferase gene were epigenetically
modiﬁed. We compared reporter expression of the trans-
fected cells treated with an inhibitor of HDACs (TSA)
and/or DNMTs (5-aza-20-dC) with that of the transfected
cells treated with the control vehicle (DMSO). TSA and
5-aza-20-dC derepressed transcription of the pGL2-
CDKN1A-Luc (131 bp) plasmid in HEK293 cells. In
the presence of ectopic FBI-1 and MBD3, which
increase BCoR binding, strong derepression was
observed in the treatment with a combination of TSA
and 5-aza-20-dC (Figure 6A and Supplementary Figure
S6). Furthermore, ChIP assays of the histone marks of
transcriptional activation (H3K4-Me3) and repression
(H3K9-Me3) around the region juxtaposed to the
proximal promoter showed that acetylated histone H3
and H3K4-Me3 are increased and H3K9-Me3 is decreased
by TSA or 5-aza-20-dC treatment (Figure 6B). The data
suggest that a nucleosome-like structure can be formed
around the short proximal promoter of pGL2-CDKN1A-
Luc (133 bp) exogenously introduced and the CDKN1A
promoter can be transcriptionally repressed by histone
deacetylation and DNA methylation.
Accordingly, we examined whether the endogenous
CDKN1A promoter of HEK293 cells could be methylated
by FBI-1 and/or MBD3 using a Me-DIP assay kit
(Methylated DNA Immunoprecipitation kit; Diagenode),
which uses an antibody against methylated DNA. MBD3
or FBI-1 each increased methylation levels by >2-fold. In
combination, they increased methylation by >3.5-fold; the
two factors had no effect on the methylation status of
positive or negative control promoters (Figure 6C and
D). Knock-down of MBD3 and/or FBI-1 mRNA
(Figure 6C and E) caused a signiﬁcant decrease in DNA
methylation of the CDKN1A proximal promoter and had
no signiﬁcant effect on the control promoters (Figure 6E
and Supplementary Figure S8). The Me-DIP assays
suggested that transcription of the CDKN1A proximal
promoter might be repressed as a result of DNA methy-
lation by the complex containing FBI-1 and MBD3.
Furthermore, bisulfate DNA sequencing of the
CDKN1A promoter showed that the core CpG bases of
Sp1 binding GC-boxes #2, #3 and #4 were more heavily
methylated than the Sp1 binding CpG bases of GC-boxes
#1, #5 and #6. The methylation of CpG bases was signiﬁ-
cantly increased by expression of FBI-1 and/or MBD3
4.7±0.09-fold (control 13–60%) for FBI-1 only,
3.8±0.07-fold (control to 13–60%) for MBD3 only,
and 5.2±0.05-fold (control to 13–60%) for FBI-1 and
MBD3 (Figure 6G and Supplementary Figure S7).
Figure 5. Continued
of MBD3 expression. The binding of FBI-1 and MBD3 is also shown. The negative control was IgG. (E) qChIP assays of co-repressor, FBI-1 and
MBD3 binding at the 30-UTR of CDKN1A, a qChIP assay control DNA region. The negative control was IgG. (F) Semi-quantitative ChIP assay of
histone modiﬁcations at the proximal promoter of endogenous CDKN1A gene by ectopic FBI-1 and/or MBD3 expression. Histone marks indicating
active transcription (acetylated H3 and H4, H3K4-Me3) and repressed transcription (H3K9-Me3) were tested. (G) qChIP analysis of histone
modiﬁcations (H3K4-Me3; H3K9-Me3) at the proximal promoter of the endogenous CDKN1A gene by ectopic expression or knock-down of
MBD3 and/or MBD3 expression. N.C., negative control scrambled siRNA. (H) qChIP analysis of histone modiﬁcations (H3K4-Me3; H3K9-
Me3) on the endogenous CDKN1A gene by knock-down of MBD3 or BCoR. N.C., negative control scrambled siRNA. (I). qChIP analysis of
BCoR and MBD3 binding to the endogenous CDKN1A gene after knock-down of MBD3 or BCoR expression. (J) RT-qPCR analyses of knock-
down efﬁciency of MBD3 or BCoR mRNA by siRNA.
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Figure 6. The CDKN1A gene is repressed by HDAC and DNA methylation; FBI-1 and MBD3 are important in DNA methylation. (A) Effect of the
HDAC inhibitor, TSA (200 nM), and DNA methylation inhibitor, 5-aza-20-deoxycytidine (1mM), on the transcription of pGL2-CDKN1A-Luc
(131 bp) repressed by FBI-1 and/or MBD3. (B) qChIP assays of acetylated H3 and H4, H3K4-Me3 and H3K9-Me3 around the exogenous
proximal CDKN1A promoter introduced by transfection, before and after treatment with TSA and 5-aza-20-deoxy-cytidine. (C) Structure of the
human CDKN1A gene promoter. Arrows at the promoter region indicate the locations of ChIP PCR primer sets. (D–F) Me-DIP assay of DNA
methylation at the proximal promoter of the endogenous CDKN1A gene after ectopic expression or knock-down of FBI-1 and/or MBD3. Me-PC,
methylation positive control (a positive signal is obtained for methylation) (Diagenode); Me-NC, methylation negative control (no signal is obtained
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Knock-down of FBI-1 and/or MBD3mRNA signiﬁcantly
decreased CpG methylation 0.5±0.05-fold (control 18–
10%) for FBI-1 siRNA only, 1.1±0.06-fold (control 18–
10%) for MBD3 siRNA only and 0.5±0.05-fold (control
18–10%) for FBI-1 and MBD3 siRNA (Figure 6H and
Supplementary Figure S7). It appears that knock-down
of ether FBI-1 or MBD3 weakly affects the methylation
of the CDKN1A promoter. The knock-down experiments
aim to decrease the FBI-1 and/or MBD3 already
expressed at low levels that have little effect on methyla-
tion. These data imply that transcription of the
endogenous CDKN1A promoter can be repressed by
DNA methylation established by a series of molecu-
lar events including histone deacetylation, histone
demethylation/methylation, which is initiated by binding
of FBI-1 and MBD3.
FBI-1, MBD3 and BCoR play roles in recruiting the
Mi-2/NuRD-HDAC complex, DNMTs and HP1 to
methylate CDKN1A promoter DNA.
Although MBD3 has no direct DNA-binding activity, we
have shown that MBD3 can be recruited to methylated or
non-methylated DNA by interacting with FBI-1. Because
MBD3 is one of the subunits of the Mi-2/NuRD-HDAC
complex, we tested whether the Mi-2/NuRD-HDAC
complex is recruited to theCDKN1A promoter by interact-
ing with FBI-1. Co-IP with the diagnostic subunits of the
NuRD complex and western blotting showed that FBI-1
forms a complex composed of MBD3, Mi-2, MTA2, most
notably in the cells co-transfected with FBI-1 and MBD3
(Figure 7A). DNMTs and HP1 proteins known to be
associated with Mi-2/NuRD-HDAC were also detected
in the immunoprecipitated complex (Figure 7A, right)
(34).
We found that the molecular interaction between the
co-repressor (NCoR, SMRT, BCoR) and FBI-1 was
affected by MBD3, and the interaction between BCoR
and FBI-1 was signiﬁcantly increased. We suspected that
such changes introduced by MBD3 might be important
in gene silencing by DNA methylation. Co-IP with
the BCoR antibody and western blotting showed
that BCoR forms a complex with FBI-1, Mi-2/NuRD-
HDAC complex, DNMTs and HP1 proteins
(Figure 7B). By ectopic expression of BCoR, BCoR inter-
action with HDAC1, DNMT1 and DNMT3b is greatly
enhanced, which may suggest more strong or direct inter-
action between BCoR and HDAC1or DNMTs
(Figure 7B).
We tested whether the Mi-2/NuRD-HDAC complex
was recruited by FBI-1 to the CDKN1A promoter using
ChIP assays with the anti-MTA2 and anti-DNMTs
antibodies. MTA2 binding was increased by MBD3,
and FBI-1, but most signiﬁcantly by MBD3/FBI-1
co-expression (Figure 8A and B). Knock-down of
MBD3 expression resulted in decreased MTA2 binding,
suggesting that the NuRD complex is recruited to the
CDKN1A promoter through the FBI-1–MBD3 inter-
action. Interestingly, knock-down of BCoR also resulted
in a drastical decrease in MTA2 binding (Figure 8C).
Because the interaction between FBI-1 and MBD3 signiﬁ-
cantly increases BCoR binding, BCoR may be important
in the recruitment of Mi-2/NuRD-HDAC or BCoR may
be a critical subunit of the Mi-2/NuRD-HDAC complex
assembly as suggested by co-IP of BCoR and Mi-2/
NuRD-HDAC complex (Figure 7B).
Furthermore, by ChIP assays, we investigated whether
the recruitment of the DNMTs and HP1 associated with
Mi-2/NuRD-HDAC complex is also increased by ectopic
FBI-1 or/and MBD3. For DNMT1 and 3b, ectopic FBI-1
or MBD3 increased DNMT binding by 3- to 5-fold and
co-expression of the two proteins increased DNMT
binding by 6- to 8-fold. Knock-down of MBD3 or FBI-
1 resulted in a 30–40% decrease in DNMT binding and
knock-down of the two proteins resulted in a 60%
decrease in DNMT binding (Figure 8D; Supplementary
Figure S4A and B). In particular, knock-down of BCoR
mRNA potently decreased DNMTs binding. We observed
a similar binding pattern for HP1 (Figure 8F). In the
presence of MBD3 and/or FBI-1, HP1 binding is
increased in a pattern similar to the Mi-2/NuRD-HDAC
complex and DNMT binding (Figure 8B–D). On knock-
down of MBD3 or BCoR mRNA, HP1 binding is
decreased (Figure 8G) and suggests that recruitment of
the Mi-2/NuRD-HDAC complex is important in
DNMT and HP1 binding.
HP1 and DNMTs were shown to form a complex
(35,36). It was proposed that the complex is recruited to
the regulatory DNA region by the HP1-H3K9-Me3 inter-
action and methylated DNA (37). However, knock-down
of HP1 mRNA showed only weak effects on DNMT
binding (Figure 8H) and suggested the importance of the
DNMTs associated with the Mi-2/NuRD-HDAC complex
in methylation of the promoter DNA. While HP1 binding
is affected by FBI-1 and/or MBD3, knock-down of HP1
mRNA does not affect FBI-1 binding and recruitment of
MBD3, andMi-2/NuRD-HDAC complex (Supplementary
Figure S5A and B). Interestingly, knock-down of HP1
mRNA resulted in increase in acetylated histones H3 and
H4, H3K4-Me3 and decrease in H3K9-Me3, suggesting
transcription repressor role of HP1, but how HP1 affects
histone modiﬁcations is unknown.
The changes in binding patterns for the Mi-2/NuRD-
HDAC complex, DNMT1/3b and HP1 by ectopic expres-
sion or knock-down of FBI-1 and/or MBD3mRNA are
Figure 6. Continued
for 0% methylation); GAPDH, GAPDH promoter (no signal is expected as this region is not methylated); Alpha X1, X-linked alpha-satellites
(a positive signal is expected as it is a methylated region). (F) qRT-PCR showed that FBI-1 and MBD3 expression are knocked down efﬁciently.
(G and H) Bisulﬁte DNA sequencing assays. The percentage of methylated cytosines in the CDKN1A promoter under various assay conditions is
shown. Cells were transfected with expression vectors or siRNA containing knocked down FBI-1 and/or MBD3, and DNA was prepared for bisulﬁte
sequencing. Individual PCR products were cloned, and 20 clones were sequenced. Filled circles on the proximal promoter sequence indicate the CpG
sites that can be methylated.
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well reﬂected by the changes in epigenetic histone marks
for the transcriptionally active or silent states. While
ectopic FBI-1 and/or MDB3 increases the amount of the
transcription repression histone mark H3K9-Me3, knock-
down of FBI-1 and/or MBD3 increased Ac-H3, Ac-H4
and H3K4-Me3, indicating transcription derepression
(Supplementary Figure S4C and D). These results
suggest that FBI-1, BCoR and MBD3 are important in
binding of the Mi-2/NuRD-HDAC complex, DNMTs
and HP1, which are important in epigenetic histone modi-
ﬁcation, promoter DNA methylation and heterochroma-
tin formation around the CDKN1A promoter.
MBD3 and FBI-1 repress transcription of CDKN1A by
histone modiﬁcation and DNA methylation of the
proximal promoter in primary HDFn cells
We examined whether the epigenetic silencing of
CDKN1A by MBD3 and FBI-1 that we observed in
various cancer and immortalized cells could also be
possible in primary human cells such as HDFn cells.
MBD3 and/or FBI-1 affected the transcriptional repres-
sion of endogenous CDKN1A in HDFn cells. FBI-1 or
MBD3 alone repressed the expression of p21. However,
when FBI-1 and MBD3 were co-transfected, strong re-
pression of p21 was observed at both mRNA and
protein levels (Figure 9A and B). Knock-down of FBI-1
and/or MBD3 resulted in the derepression of p21 expres-
sion (Figure 9C and D).
We also examined the changes in epigenetic histone
marks around the proximal promoter of CDKN1A
caused by ectopic FBI-1 and MBD3 expression or
knock-down of FBI-1 and MBD3 mRNA. The two
proteins decreased indicators of active transcription such
as acetylated histones H3 and H4 and the trimethylated
histone H3K4 (indicators of active transcription) while
increasing the trimethylated histone H3K9, indicating
transcriptional repression (Figure 9F and G).
Me-DIP assays of the endogenous CDKN1A promoter
in HDFn cells showed that MBD3 and FBI-1 each
increased methylation levels by >7-fold. In combination,
they increased methylation by >12-fold; the two factors
had no effect on the methylation status of positive or
negative control promoters (Figure 9H). Knock-down of
MBD3 and/or FBI-1mRNA (Figure 9C) caused a signiﬁ-
cant decrease in DNA methylation of the CDKN1A
proximal promoter and had no signiﬁcant effect on the
control promoters (Figure 9I). This result suggests that
transcription of the CDKN1A proximal promoter might
be repressed by DNA methylation of the complex contain-
ing FBI-1 and MBD3 in HDFn cells.
Figure 7. FBI-1 and BCoR interact with the MBD3-Mi-2/NuRD-HDAC complex, DNMT1, DNMT3b and HP1. (A) Co-IP and western blot
analysis of FBI-1, MBD3, the Mi-2/NuRD-HDAC complex, DNMTs and HP1. HEK293 cells were transfected with the FBI-1 and/or MBD3
expression vector and immunoprecipitated using an anti-FBI-1 antibody. The immunoprecipitates were analysed for the presence of FBI-1, MBD3,
the Mi-2/NuRD-HDAC complex, DNMTs and HP1. GAPDH was used as the loading control. (B) Co-IP and western blot analysis of FBI-1, BCoR,
MBD3, the Mi-2/NuRD-HDAC complex, DNMTs and HP1. HEK293 cells were transfected with the BCoR expression vector and immunopre-
cipitated using an anti-BCoR antibody. The immunoprecipitates were analysed for the presence of FBI-1, MBD3, the Mi-2/NuRD-HDAC complex,
DNMTs and HP1. GAPDH was used as the loading control.
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DISCUSSION
FBI-1 is a proto-oncogenic transcription factor that is
overexpressed in various human cancer tissues. It
represses the transcription of ARF and CDKN1A, which
play critical roles in cellular transformation, cell prolifer-
ation and oncogenesis (1–3). Tumour-suppressor genes
like CDKN1A are often repressed in cancer tissues and
remain in a repressed state during successive stages of
cell proliferation. Previously, we demonstrated that FBI-
1 interacts with co-repressor/HDAC complexes to repress
the transcription of CDKN1A by histone deacetylation (1).
Studies of the methylation status of the CDKN1A
promoter in bone marrow cells in 124 patients with
acute lymphoblastic leukaemia showed hypermethylation
in 41% (51 of 124) of these patients. Hypermethylation
within the promoter strongly correlated with decreased
CDKN1A mRNA expression in tumour cells and such
patients showed poor prognoses (31).
We have previously shown that, to repress the transcrip-
tion of CDKN1A, FBI-1 binds to the proximal promoter
Sp1 binding GC-box #3 (or FRE), which is critical in
transcription initiation and activation by interaction
with Sp1 and by p53 bound at the distal regulatory
elements of CDKN1A (1,38). The transcription of
CDKN1A is derepressed by both TSA and 5-aza-20-
deoxycitidine, suggesting that the gene is repressed by a
mechanism involving histone deacetylation and DNA
methylation. We suspected that FBI-1 might also play a
role in establishing and maintaining epigenetically silent
CDKN1A by DNA methylation in cancer cells. We also
found that FBI-1 interacts with MBD3 and that the mo-
lecular events initiated by the interaction are important in
the epigenetic silencing of CDKN1A by DNA methylation
(Figure 10, hypothetical model).
MBD family proteins are known to bind to methylated
DNA and repress transcription, with the exception of
Figure 8. MBD3 and BCoR play critical role in the recruitment of Mi-2/NuRD-HDAC complex and subsequent binding of DNMTs and HP1.
(A) Structure of human CDKN1A gene promoter. Arrows indicate the locations of qChIP PCR primer binding sites. (B) qChIP assays of Mi-2/
NURD-HDAC complex (as tested for diagnostic subunit MTA2) binding at the endogenous CDKN1A promoter of the cells transfected with FBI-1
or/and MBD3. (C) qChIP assays of the Mi-2/NuRD-HDAC complex binding at the endogenous CDKN1A promoter after knockdown of MBD3 or
BCoR. Knockdown of MBD3 or BCoR expression decrease Mi-2/NuRD-HDAC complex binding. (D) qChIP assays of DNMT1 binding in
HEK293 cells. HEK293 cells were transfected with ectopic expression vectors or knockdown siRNA of MBD3 or/and FBI-1. Chromatin was
ﬁxed and DNMT binding was analyzed by qChIP. (E) qChIP assays of the DNMT1 binding at the endogenous CDKN1A promoter after
knockdown of MBD3 or BCoR. Knockdown of MBD3 or BCoR expression potently decrease DNMT recruitment. (F) qChIP assays of HP1
binding to the endogenous CDKN1A promoter in HEK29A cells, in the presence of ectopic MBD3, FBI-1 or siRNA against MBD3 or BCoR.
(G) qChIP assays of the HP1 binding at the endogenous CDKN1A promoter after knockdown of MBD3 or BCoR. Knockdown of MBD3 or BCoR
expression decrease HP1 recruitment. (H) qChIP assays of DNMT1 or 3b binding. HEK293 cells were transfected with HP1 siRNA and analyzed for
DNMTs binding.
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Figure 9. MBD3 and FBI-1 repress the transcription of CDKN1A by histone modiﬁcation and DNA methylation in primary human HDFn cells.
(A and B) RT-qPCR and western blot analysis of p21 expression in HDFn cells transfected with FBI-1 and/or MBD3 expression vectors. Ectopic
FBI-1 and/or MBD3 decrease endogenous p21 expression. (C and D) RT-qPCR and western blot analysis of p21 expression in HDFn cells
transfected with siRNA designed to knock down endogenous FBI-1 and/or MBD3 expression. Knock-down of FBI-1 and/or MBD3 increases
endogenous p21 mRNA expression. (E) Structure of the human CDKN1A gene promoter. Arrows indicate the locations of the ChIP PCR primer-
binding sites. (F) qChIP analysis of histone modiﬁcations at the proximal CDKN1A promoter caused by FBI-1 and/or MBD3 expression. Histone
marks indicating active transcription (acetylated H3 and H4, H3K4-Me3) and repressed transcription (H3K9-Me3) were tested. The negative control
was IgG. (G) qChIP analysis of histone modiﬁcations at the proximal promoter of the endogenous CDKN1A gene by knock-down of endogenous
FBI-1 and/or MBD3 expression. The negative control was IgG. (H and I) Me-DIP assay of DNA methylation at the proximal CDKN1A promoter
after ectopic expression or knock-down of FBI-1 and/or MBD3. Me-PC, methylation positive control; Me-NC, methylation negative control;
GAPDH, GAPDH promoter; Alpha X1, X-linked alpha-satellites.
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MBD3, which is one of components of the Mi-2/NuRD-
HDAC complex. MBD3 was shown to act as a transcrip-
tional repressor by recruiting HDACs and DNMTs, which
are important in oncogenic transformation and cell prolif-
eration (20,39). An accepted role of MBD3 in transcrip-
tional repression is by histone deacetylation by HDAC1
and HDAC2 associated with the Mi-2/NuRD-HDAC
complex [(18) and references therein]. Recently, MBD3
was shown to be associated with the CDKN1A promoter
and was dissociated from the promoter on TSA treatment;
the functional signiﬁcance of MBD3 binding remained
unknown [(19) and references therein; (21)].
Previously, we found that FBI-1 interacts with the co-
repressors SMRT, NCoR and SIN3A to repress transcrip-
tion via histone modiﬁcations around the proximal
promoter region. MBD3 enhanced transcription of the
CDKN1A gene by FBI-1 (1). Initially, we suspected that
additional recruitment of the co-repressors might be re-
sponsible for the increased repression. However, we
found that binding of the above-mentioned co-repressors
to the proximal promoter region was decreased. Intrigued
by this ﬁnding, we investigated and successfully showed
that, by interacting with FBI-1, MBD3 is targeted to the
FRE of the proximal CDKN1A promoter and enhances
transcription repression by FBI-1. MBD3 recruited by
FBI-1 controls which co-repressor interacts with FBI-1.
Although FBI-1 can interact with NCoR, SMRT and
BCoR, MBD3 leads FBI-1 to interact primarily with
BCoR to repress the transcription of CDKN1A by DNA
methylation. The transition of interacting co-repressor
with BCoR increased the binding of the Mi-2/NuRD-
HDAC complex (Figure 7B), resulting in the deacetylation
of histones, demethylation of histone H3K4 and an
increase in trimethylation of histone H3K9. BCoR plays
a critical role in Mi-2/NuRD-HDAC complex recruitment
(Figure 7B and 8C). In addition, DNMTs and
HP1 proteins associated with the Mi-1/NuRD-HDAC
complex are recruited to methylate DNA and to
maintain epigenetically repressed states (Figure 10).
Accordingly, by interacting with FBI-1, MBD3 may be
engaged in both de novo methylation and also mainten-
ance of the methylated CDKN1A promoter by recruitment
of DNMTs. It was reported that DNMT1 represses the
CDKN1A promoter. But the mechanism of DNMT1
action on the promoter remained unknown (25,26). Our
study showed how DNMTs are recruited to the CDKN1A
promoter region and can repress transcription by DNA
methylation in the presence of FBI-1, MBD3 and BCoR.
Interestingly, FBI-1 could bind both non-methylated
and methylated DNA, a property similar to that of
another methylated DNA–binding protein, KAISO.
FBI-1 not only represses transcription of its target genes
by histone deacetylation, but also it can silence its target
genes by DNA methylation involving MBD3 and BCoR.
By interacting with MBD3 and recruiting BCoR to the
FBI-1-MBD3 complex to the CDKN1A promoter, FBI-1
can repress CDKN1A expression and stimulate cell prolif-
eration. We have previously demonstrated that FBI-1
regulates the p53 pathway genes, which are important in
regulating cell proliferation. ChIP-on-ChIP analysis of the
FBI-1 target genes in HepG2 cells revealed that numerous
Figure 10. Hypothetical model of epigenetic silencing of the CDKN1A
gene by FBI-1, MBD3 and BCoR, and DNA methylation by DNMT1/
3b. (A) In normal cells with no or low FBI-1, transcription of
CDKN1A is mainly regulated by Sp1 family proteins acting on GC-
boxes of the proximal promoter, and cells express basal levels of p21.
PCAF/p300, co-activator with HAT activity. Histones are acetylated
and rich in H3K4-Me3. Few CpG are methylated. (B) With a high
level of FBI-1, FBI-1 binds to the FRE (GC-box #3) critical in tran-
scription initiation and activation, and interacts with a co-repressor
(SMRT/NCoR) to repress transcription by deacetylation of histones
H3 and H4, demethylation of H3K4-Me3 and methylation of H3K9.
In this case, SMRT/NCoR competes with BCoR to interact with FBI-
1. (C) In the presence of MBD3 and FBI-1, MBD3 binds to the zinc-
ﬁnger domain of FBI-1 and recruits the Mi-2/NuRD-HDAC complex
and directs FBI-1 to interact primarily with BCoR co-repressor. MBD3
and BCoR play critical roles in the recruitment of the Mi-2/NuRD-
HDAC complex. Eventually, DNMT1/3b and HP1 proteins associated
with the NuRD complex are recruited to methylate the promoter DNA,
which forms a heterochromatin structure in the region.
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genes important in cell metabolism and cell proliferation
are targets of FBI-1 (40). Accordingly, these genes, either
methylated or non-methylated, are likely regulated by
FBI-1, MBD3 and BCoR in a manner similar to
CDKN1A.
The epigenetic gene silencing observed for FBI-1 might
also be applicable to other POK family transcription
factors. For example, proto-oncoprotein BCL6 was
shown to interact with the co-repressors SMRT, NCoR
and BCoR (BCL6 co-repressor) in a mutually exclusive
fashion (41). The BCoR complex contains polycomb
group protein (PcG), E3 ubiquitin ligase and histone
H3K36 demethylase, suggesting that BCoR may use epi-
genetic modiﬁcation to silence gene expression (42). BCL6
also interacts with the MBD3-Mi-2/NuRD-HDAC
complex to repress transcription of plasma-speciﬁc genes
to determine the cell fate of B lymphocytes (43). BCoR
was shown to regulate mesenchymal stem cell function by
an epigenetic mechanism (44). The molecular mechanism
we found here may give insight into the role of BCL6 and
its interaction with BCoR in the epigenetic regulation
of BCL6 target genes, including CDKN1A and
TP53. Interestingly, it was demonstrated that BTB/POZ
protein HIC1 target genes are differentially regulated by
CtBP and NuRD via an acetylation/SUMOylation switch.
HIC1 participates in the complex regulation of the genes
crucial for cell growth and survival through gene-speciﬁc
co-repressor recruitment (45).
Although involvement of BCoR was not illustrated,
a similar epigenetic silencing mechanism involving Mi-2/
NuRD-HDAC complex seems to be used by the
oncoprotein, PML-RARa. PML-RARa binds and
recruits Mi-2/NuRD-HDAC to the tumour-suppressor
gene RARb2 to silence the RARb2 promoter. The Mi-2/
NuRD-HDAC complex plays a direct role in the aberrant
gene repression and transmission of epigenetic repressive
marks in acute promyelocytic leukaemia (APL) (39). The
Mi-2/NuRD-HDAC complex facilitates polycomb
binding and histone methylation at lysine 27. Knock-
down of the Mi-2/NuRD-HDAC complex in leukaemic
cells not only prevented histone deacetylation and chro-
matin compaction but also impaired DNA and histone
methylation and stable silencing. Mi-2/NuRD-HDAC
plays an important role in the establishment of altered
epigenetic marks in APL.
Overall, our studies suggest that FBI-1 recruits BCoR
and the Mi-2/NuRD-HDAC complex to the CDKN1A
promoter through interaction with MBD3, which is
followed by histone modiﬁcations, DNA methylation,
HP1 binding and epigenetic silencing of CDKN1A. The
molecular events that lead to promoter DNA methylation
of CDKN1A may be important in the oncogenic ability of
FBI-1 and cell proliferation.
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